Front. Oncol. Frontiers in Oncology Front. Oncol. 2234-943X Frontiers Media S.A. 10.3389/fonc.2023.1208634 Oncology Erratum Erratum: Safety and feasibility of robotic-assisted thoracic surgery after neoadjuvant chemoimmunotherapy in non-small cell lung cancer Frontiers Production Office * Frontiers Media SA, Lausanne, Switzerland

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Frontiers Production Office, production.office@frontiersin.org

03 05 2023 2023 13 1208634 19 04 2023 19 04 2023 Copyright © 2023 Frontiers Production Office 2023 Frontiers Production Office

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 An Erratum on Safety and feasibility of robotic-assisted thoracic surgery after neoadjuvant chemoimmunotherapy in non-small cell lung cancer. By Zeng J, Yi B, Chang R, Chen Y, Yu Z and Gao Y (2023) Front. Oncol. 13:1134713. doi: 10.3389/fonc.2023.1134713 non-small-cell lung cancer neoadjuvant chemoimmunotherapy robotic-assisted thoracic surgery video-assisted thoracic surgery safety and feasibility section-at-acceptance Surgical Oncology

Due to a production error, there was a mistake in Table 4 as published. The heading “Index” was incorrectly repeated and the subheadings “VATS(n=78)”, “RATS (n=142)”, “P”, “VATS”, “RATS”, and “P” were positioned above the incorrect columns. The corrected Table 4 appears below.

Unadjusted and IPTW adjusted perioperative outcomes.

Without IPTW With IPTW
Index VATS(n=78) RATS (n=142) P VATS RATS P
90-day mortality 0(0) 0(0) >0.990 0% 0% >0.990
LOS after surgery, mean (SD), d 6.01(3.00) 6.78(4.07) 0.145 6.18(3.11) 6.75(4.22) 0.298
VAS score after surgery, mean (SD) 4.41(0.93) 3.77(1.21) 0.002 4.47(0.97) 3.71(1.22) <0.001
VAS score at discharge, mean (SD) 1.71(0.68) 1.27(0.57) 0.267 1.69(0.67) 1.31 (0.56) 0.375
ADL score at discharge, mean (SD) 59.49(11.29) 62.22(12.27) 0.106 59.60(11.25) 62.27(12.22) 0.138
Drainage volume, mean (SD), ML 452.05(399.10) 439.33(304.18) 0.791 459.00(300.06) 431.37(288.50) 0.461
Drug cost, mean (SD), $ 1320.70(638.73) 1579.58(1178.16) 0.355 1336.06(668.59) 1571.83(1359.65) 0.087

SD, standard deviation; LOS, length of stay; VAS, visual analogue scale; ADL, activities of daily living, IPTW, inverse probability treatment weight; VATS, video-assisted thoracic surgery; RATS, robotic-assisted thoracic surgery.

The publisher apologizes for this mistake. The original version of this article has been updated.